ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer,... Read More
Preliminary computerized imaging reveals the shape of the prostate and a compartment within the gland–called the transitional zone–consistently differ in... Read More
In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the first-in-human application... Read More
Canadian prostate cancer researchers have discovered the genetic fingerprint that explains why up to 30 per cent of men with... Read More
Scientists at The Wistar Institute have identified a novel protein pathway across several types of cancer that controls how tumor... Read More
A new report on Swedish men with non-aggressive prostate cancer suggests that a lot more American men could safely choose... Read More
